X

Pressure Biosciences Inc. (PBIO.OB) Intends to Continue Adding Additional Research and Development Projects as well as Personnel to Expand Product Substantiation

In an effort to commercialize its products, the company is adding research scientists. They believe that investment in these additional personnel will be beneficial to the implementation of its commercialization plan in two key ways. First, through the publication of uses for current products, and secondly through further inventions that rely on the company’s PCT™ technology. This will ultimately expand the scope of its current products and projects enhancing the company’s strategic position.

A recent study conducted noted that the company’s PCT™ technology helped identify potential colon Biomarkers. Annual Scientific Meeting of the American College of Gastroenterology (ACG) presented the study. Identification of Biomarkers enables doctors to identify the disease earlier and have a higher treatment success rate.

In a related story, the company also received the 2007 North American Frost and Sullivan Award for Technology Innovation, given to companies that have demonstrated excellence in new products and technologies within their industry. The award is for the company’s “development of a method for the detergent-free extraction of proteins from lipid-rich tissues.” PCT™ technology, along with the ProteoSolveLRS kit, resulted in a higher retention of proteins and faster process that is much easier to reproduce.

The company is showing internal as well as external validation of its technology. In addition, it continues to show many other uses for Pressure Cycling Technology. This greatly enhances the attractiveness of the technology and company as it strengthens its strategic position within the marketplace and commercializes its technologies.

Pressure Bioscience is early stage company that focuses on creating and developing innovative technologies, specifically the company has patented Pressure Cycling technology for sample preparation. Its Barocycler NEP3229 uses this technology to process multiple samples within minutes with the ability to customize depending on the sample type needed. They hold 13 US and 4 foreign patents covering many applications of their technology in the life sciences field.

Let us hear your thoughts: Pressure BioSciences, Inc. Message Board

Related Post